tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride

Catalog No. :
ACMKVA285
CAS No. :
1788044-12-1
Molecular Formula :
C11H21ClN2O2
Molecular Weight :
248.75

IUPAC Name:tert-butyl (1-azaspiro[3.3]heptan-6-yl)carbamate hydrochloride

tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$330.00Login to see priceInquiryInquiry
250mg98%$631.00Login to see priceInquiryInquiry
1g98%$1319.00Login to see priceInquiryInquiry
5g98%$3957.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride
IUPAC Nametert-butyl (1-azaspiro[3.3]heptan-6-yl)carbamate hydrochloride
MDL No.MFCD28502521
Molecular FormulaC11H21ClN2O2
Molecular Weight248.75
SMILESO=C(OC(C)(C)C)NC(C1)CC21CCN2.[H]Cl
InChI KeyNOTAIHJBPKQTMR-UHFFFAOYSA-N
Synonym1788044-12-1 | tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride | 2306253-30-3 | cis-6-(boc-amino)-1-azaspiro[3.3]heptane hydrochloride | tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate HCl | TERT-BUTYL N-{1-AZASPIRO[3.3]HEPTAN-6-YL}CARBAMATE HYDROCHLORI
CAS No.1788044-12-1
PubChem CID91826004

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMKVA285 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMKVA285 route product structure diagram
    ACMKVA2851788044-12-1
Inquiry

2. ACMKVA285 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMKVA285 route product structure diagram
    ACMKVA2851788044-12-1
Inquiry

Comments (0)